The store will not work correctly when cookies are disabled.
1-(2-Oxo-2-p-tolyl-ethyl)-1H-indole-2,3-dione
ID: ALA84747
PubChem CID: 28476323
Max Phase: Preclinical
Molecular Formula: C17H13NO3
Molecular Weight: 279.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(=O)CN2C(=O)C(=O)c3ccccc32)cc1
Standard InChI: InChI=1S/C17H13NO3/c1-11-6-8-12(9-7-11)15(19)10-18-14-5-3-2-4-13(14)16(20)17(18)21/h2-9H,10H2,1H3
Standard InChI Key: PJQULSIUMHBSSF-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
4.8875 -7.3792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3667 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8792 -6.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1000 -7.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0917 -6.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1417 -8.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9417 -8.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1917 -6.7042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 -5.2625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3417 -9.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4417 -7.7167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9292 -9.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1625 -9.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -5.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3292 -10.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5667 -9.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1542 -10.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -7.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5625 -11.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6667 -6.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6667 -7.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 1 0
5 4 1 0
6 1 1 0
7 6 1 0
8 2 2 0
9 3 2 0
10 7 1 0
11 7 2 0
12 10 2 0
13 10 1 0
14 5 2 0
15 12 1 0
16 13 2 0
17 16 1 0
18 4 2 0
19 17 1 0
20 21 2 0
21 18 1 0
3 5 1 0
14 20 1 0
15 17 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.30 | Molecular Weight (Monoisotopic): 279.0895 | AlogP: 2.41 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.45 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.56 | CX LogD: 2.56 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.64 | Np Likeness Score: -0.96 |
References
1. Shuttleworth SJ, Nasturica D, Gervais C, Siddiqui MA, Rando RF, Lee N.. (2000) Parallel synthesis of isatin-based serine protease inhibitors., 10 (22): [PMID:11086715] [10.1016/s0960-894x(00)00523-0] |